基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research
Description of Research Expertise
Improved therapeutic response via metabolic modulation.
Development of a safe and reproducible method to selectively acidify and deenergize the human cancers. Specifically, we seek to employ the natural tendency of cancers to convert glucose to lactate as a method for selective intracellular acidification, which is known to potentiate tumor response to chemotherapy, radiation therapy, hyperthermia, and photodynamic therapy. In vivo 31P and 1H MRS demonstrated that human cancer xenografts such as melanoma, breast, prostate, ovarian and glioma in immunosuppressed mice treated with metabolic modulators exhibit a sustained and tumor-selective decrease in pH, bioenergetics and increase in lactate and subsequent sensitization to chemo- and radiation therapy.
Expertise
Mouse xenograft development, tumor cells studies, drug delivery, metabolomics, and tumor micro-environment modulation.
Surface coil development to perform MRI/MRS studies on preclinical models.
1H, 31P, 13C MRS.
T1, T2, DTI, DCE MRI.
Measurement of test-retest reproducibility of SUV on PET in cancer patients.
Description of Research Expertise
Improved therapeutic response via metabolic modulation.
Development of a safe and reproducible method to selectively acidify and deenergize the human cancers. Specifically, we seek to employ the natural tendency of cancers to convert glucose to lactate as a method for selective intracellular acidification, which is known to potentiate tumor response to chemotherapy, radiation therapy, hyperthermia, and photodynamic therapy. In vivo 31P and 1H MRS demonstrated that human cancer xenografts such as melanoma, breast, prostate, ovarian and glioma in immunosuppressed mice treated with metabolic modulators exhibit a sustained and tumor-selective decrease in pH, bioenergetics and increase in lactate and subsequent sensitization to chemo- and radiation therapy.
Expertise
Mouse xenograft development, tumor cells studies, drug delivery, metabolomics, and tumor micro-environment modulation.
Surface coil development to perform MRI/MRS studies on preclinical models.
1H, 31P, 13C MRS.
T1, T2, DTI, DCE MRI.
Measurement of test-retest reproducibility of SUV on PET in cancer patients.
Research Interests
Papers共 78 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pradeep Kumar Gupta,Stepan Orlovskiy,Fernando Arias-Mendoza, David S. Nelson, Aria Osborne,Stephen Pickup,Jerry D. Glickson,Kavindra Nath
CANCERSno. 2 (2024): 365
RSC Advancesno. 29 (2023): 19813-19816
NMR IN BIOMEDICINEno. 4 (2023)
Narayan Datt Soni,Anshuman Swain,Paul Jacobs, Halvor Juul, Ryan Armbruster, Ravi Prakash Reddy Nanga,Kavindra Nath,Corinde Wiers,John Detre,Ravinder Reddy
Magnetic resonance in medicine (2023)
RSC advancesno. 29 (2023): 19813-19816
Narayan Datt Soni,Anshuman Swain,Paul Jacobs, Halvor Juul, Ryan Armbruster, Ravi Prakash Reddy Nanga,Kavindra Nath,Corinde Wiers,John Detre,Ravinder Reddy
MAGNETIC RESONANCE IN MEDICINEno. 1 (2023): 259-269
Narayan Datt Soni,Anshuman Swain,Paul Jacobs, Halvor Juul, Ryan Armbruster, Ravi Prakash Reddy Nanga,Kavindra Nath,Corinde E. Wiers,John A. Detre,Ravinder Reddy
Magnetic Resonance in Medicineno. 1 (2023): 259-269
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn